Healthcare


 Biosergen Provides Phase 2 Clinical Development Strategy Update

Biosergen Provides Phase 2 Clinical Development Strategy Update

March 29, 2023 05:48 PM AEDT | By Reuters

March 29 (Reuters) - Biosergen AB: * BIOSERGEN PROVIDES PHASE 2 CLINICAL DEVELOPMENT STRATEGY UPDATE * BASED ON DATA FROM COMPLETED PHASE I TRIAL, CO...

 Toleranzia Files Patent Application For Tolerogen Combination Treatments

Toleranzia Files Patent Application For Tolerogen Combination Treatm...

March 29, 2023 04:36 PM AEDT | By Reuters

March 29 (Reuters) - Toleranzia AB: * TOLERANZIA FILES PATENT APPLICATION FOR TOLEROGEN COMBINATION TREATMENTS Source text for Eikon: Further company...

 Scandinavian Chemotech Receives Granted Patent In U.S.

Scandinavian Chemotech Receives Granted Patent In U.S.

March 29, 2023 01:53 AM AEDT | By Reuters

March 28 (Reuters) - Scandinavian ChemoTech AB : * SCANDINAVIAN CHEMOTECH RECEIVES A GRANTED PATENT IN THE US * PATENT AUTHORITY IN US APPROVED PATENT...

 WHO revises COVID-19 vaccine recommendations for Omicron-era

WHO revises COVID-19 vaccine recommendations for Omicron-era

March 29, 2023 01:53 AM AEDT | By Reuters

(Reuters) - The World Health Organization has tailored its COVID-19 vaccination recommendations for a new phase of the pandemic, suggesting that healt...

 WHO revises COVID-19 vaccine recommendations for Omicron-era

WHO revises COVID-19 vaccine recommendations for Omicron-era

March 29, 2023 01:46 AM AEDT | By Reuters

(Adds detail, quote from committee chair) March 28 (Reuters) - The World Health Organization has tailored its COVID-19 vaccination recommendations for...

 Equipment House Sign Contract Worth 194.8 Mln Riyals with Ministry of Health

Equipment House Sign Contract Worth 194.8 Mln Riyals with Ministry o...

March 29, 2023 12:52 AM AEDT | By Reuters

March 28 (Reuters) - SCIENTIFIC AND MEDICAL EQUIPMENT HOUSE COMPANY CJSC: * SIGN OFF CONTRACT FOR MAINTENANCE, CLEANING AND NON-MEDICAL OPERATION OF A...

 WHO changes COVID vaccine recommendations

WHO changes COVID vaccine recommendations

March 29, 2023 12:49 AM AEDT | By Reuters

(Adds details) March 28 (Reuters) - The World Health Organization on Tuesday changed its recommendations for COVID-19 vaccines, suggesting that high-r...

 WHO changes COVID vaccine recommendations

WHO changes COVID vaccine recommendations

March 29, 2023 12:28 AM AEDT | By Reuters

March 28 (Reuters) - The World Health Organization on Tuesday changed its recommendations for COVID-19 vaccines, suggesting that high-risk populations...

 Zealand Pharma Announces Positive Phase 1 Clinical Results With ZP8396

Zealand Pharma Announces Positive Phase 1 Clinical Results With ZP83...

March 28, 2023 10:38 PM AEDT | By Reuters

March 28 (Reuters) - Zealand Pharma A/S: * ZEALAND PHARMA ANNOUNCES POSITIVE PHASE 1 CLINICAL RESULTS WITH AMYLIN ANALOGUE ZP8396 * ZP8396 WAS WELL TO...

 AlzeCure Pharma Presents New Data On Its Preventive Treatment Alzstatin At Alzheimer's Conference AD/PD 2023

AlzeCure Pharma Presents New Data On Its Preventive Treatment Alzsta...

March 28, 2023 07:10 PM AEDT | By Reuters

March 28 (Reuters) - AlzeCure Pharma AB: * ALZECURE PRESENTS NEW DATA ON ITS PREVENTIVE TREATMENT ALZSTATIN AT THE ALZHEIMER'S CONFERENCE AD/PD 2023 S...

 Karolinska Development's Portfolio Co Secures Funding For Development Of Golexanolone

Karolinska Development's Portfolio Co Secures Funding For Developmen...

March 28, 2023 06:00 PM AEDT | By Reuters

March 28 (Reuters) - Karolinska Development AB : * KAROLINSKA DEVELOPMENT'S PORTFOLIO COMPANY UMECRINE COGNITION SECURES ADDITIONAL FUNDING FOR FURTHE...

 Ambu Obtains European Clearance Of Smaller Sizes Of Ambu Ascope 5 Broncho

Ambu Obtains European Clearance Of Smaller Sizes Of Ambu Ascope 5 Br...

March 28, 2023 05:44 PM AEDT | By Reuters

March 28 (Reuters) - Ambu: * OBTAINS EUROPEAN REGULATORY CLEARANCE OF ITS COMPLETE FIFTH-GENERATION BRONCHOSCOPE PORTFOLIO * REGULATORY CLEARANCE (CE...

 HBM Healthcare Investments Announces The Return Of Andreas Wicki as CEO

HBM Healthcare Investments Announces The Return Of Andreas Wicki as...

March 28, 2023 03:48 PM AEDT | By Reuters

March 28 (Reuters) - HBM Healthcare Investments AG : * HBM HEALTHCARE INVESTMENTS ANNOUNCES THE RETURN OF DR ANDREAS WICKI; NEW INVESTMENT OF USD 12 M...

 US colleges face loss of racial diversity if race-conscious admissions banned -study

US colleges face loss of racial diversity if race-conscious admissio...

March 28, 2023 03:08 PM AEDT | By Reuters

By Gabriella Borter (Reuters) - If the U.S. Supreme Court bans the consideration of race in college admissions, enrollment of minority groups at selec...

 Sofinnova Partners Launches Digital Medicine Strategy

Sofinnova Partners Launches Digital Medicine Strategy

March 28, 2023 03:05 PM AEDT | By Reuters

March 28 (Reuters) - * SOFINNOVA PARTNERS LAUNCHES DIGITAL MEDICINE STRATEGY Source text for Eikon:

 Reg-Nyxoah Raises $3 Million From An At-The-Market Equity Offering

Reg-Nyxoah Raises $3 Million From An At-The-Market Equity Offering

March 28, 2023 07:26 AM AEDT | By Reuters

March 27 (Reuters) - Nyxoah SA: * REG-NYXOAH RAISES $3 MILLION FROM AN AT-THE-MARKET EQUITY OFFERING Source text for Eikon: Further company coverage:

 Naba Alsaha Medical Services FY Profit Rises

Naba Alsaha Medical Services FY Profit Rises

March 28, 2023 01:31 AM AEDT | By Reuters

March 27 (Reuters) - NABA ALSAHA MEDICAL SERVICES COMPANY: * FY NET PROFIT AFTER ZAKAT AND TAX 26.9 MILLION RIYALS VERSUS 25.8 MILLION RIYALS YEAR AGO...

 Eplontersen Demonstrated Sustained Benefit In Phase III Trial For Hereditary Transthyretin-Mediated Amyloid Polyneuropathy Through 66 Weeks

Eplontersen Demonstrated Sustained Benefit In Phase III Trial For He...

March 28, 2023 01:23 AM AEDT | By Reuters

March 27 (Reuters) - AstraZeneca PLC: * EPLONTERSEN DEMONSTRATED SUSTAINED BENEFIT IN PHASE III TRIAL FOR HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOID PO...

 OliX Pharmaceuticals Doses First Patient In Clinical Trial For RNAi Therapeutic OLX10212 For Dry And Wet Age-Related Macular Degeneration

OliX Pharmaceuticals Doses First Patient In Clinical Trial For RNAi...

March 27, 2023 11:27 PM AEDT | By Reuters

March 27 (Reuters) - OliX Pharmaceuticals Inc : * OLIX PHARMACEUTICALS DOSES FIRST PATIENT IN CLINICAL TRIAL FOR RNAI THERAPEUTIC OLX10212 FOR DRY AND...

 Universal Vision Says 2022 Net Profit T$850.4 Mln, EPS T$10.64

Universal Vision Says 2022 Net Profit T$850.4 Mln, EPS T$10.64

March 27, 2023 08:14 PM AEDT | By Reuters

March 27 (Reuters) - Universal Vision Biotechnology Co Ltd: * SAYS 2022 NET PROFIT T$850.4 MILLION * SAYS 2022 EARNINGS PER SHARE T$10.64 Source text...

Recent Articles

 Layflat.com announces five regional training centers
December 05, 2023 06:00 PM AEDT | By EIN Presswire

 Stefan Blomsterberg appointed as new CEO of CELLINK Bioprinting AB
December 04, 2023 08:00 PM AEDT | By EIN Presswire

 Sweden-Based Crypto Tax Tool Kryptos announces ‘Elite Partners’ Program
November 25, 2023 08:00 AM AEDT | By EIN Presswire

 Sweden-based Crypto Tax Software- Kryptos Introduces Revolutionary AI Features for Easier Tax Filing
November 24, 2023 07:03 PM AEDT | By EIN Presswire

 Autodeal.se Launches to Revolutionize Sweden's E-commerce Landscape
November 24, 2023 06:42 PM AEDT | By EIN Presswire


Top LSE Listed Companies